Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Extracorporeal Membrane Oxygenation | 34 | 2021 | 5002 | 3.83 | Why? |
| Shock, Cardiogenic | 9 | 2019 | 700 | 1.48 | Why? |
| Extracorporeal Circulation | 2 | 2019 | 130 | 0.81 | Why? |
| Amikacin | 1 | 2018 | 62 | 0.73 | Why? |
| Membranes, Artificial | 1 | 2020 | 175 | 0.73 | Why? |
| Plasmapheresis | 1 | 2021 | 437 | 0.68 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2019 | 260 | 0.62 | Why? |
| Tomography | 1 | 2017 | 183 | 0.62 | Why? |
| Giant Cells | 1 | 2018 | 334 | 0.59 | Why? |
| Calcinosis | 1 | 2018 | 240 | 0.59 | Why? |
| Withholding Treatment | 1 | 2021 | 798 | 0.58 | Why? |
| Electric Impedance | 1 | 2017 | 283 | 0.58 | Why? |
| Intra-Aortic Balloon Pumping | 3 | 2019 | 125 | 0.52 | Why? |
| Intensive Care Units | 13 | 2021 | 29594 | 0.49 | Why? |
| Positive-Pressure Respiration | 2 | 2018 | 1160 | 0.47 | Why? |
| Cardiomyopathies | 2 | 2018 | 997 | 0.45 | Why? |
| Carbon Dioxide | 1 | 2018 | 917 | 0.43 | Why? |
| Myocarditis | 4 | 2020 | 2731 | 0.42 | Why? |
| Respiration, Artificial | 8 | 2021 | 22116 | 0.39 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.37 | Why? |
| Paris | 3 | 2021 | 1287 | 0.33 | Why? |
| Tidal Volume | 2 | 2018 | 565 | 0.28 | Why? |
| Pulmonary Embolism | 3 | 2021 | 4775 | 0.28 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2018 | 1876 | 0.27 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.26 | Why? |
| Heart-Assist Devices | 4 | 2019 | 812 | 0.25 | Why? |
| Renal Dialysis | 1 | 2020 | 4358 | 0.25 | Why? |
| Respiratory Insufficiency | 4 | 2019 | 7301 | 0.25 | Why? |
| Critical Illness | 4 | 2019 | 17281 | 0.24 | Why? |
| Heart Failure | 3 | 2018 | 6638 | 0.23 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.23 | Why? |
| Ventricular Dysfunction, Left | 2 | 2020 | 993 | 0.22 | Why? |
| Purpura Fulminans | 1 | 2019 | 22 | 0.20 | Why? |
| France | 7 | 2021 | 12074 | 0.20 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.20 | Why? |
| Middle Aged | 28 | 2021 | 270681 | 0.19 | Why? |
| Femoral Vein | 1 | 2018 | 43 | 0.19 | Why? |
| Survival Rate | 5 | 2020 | 9206 | 0.18 | Why? |
| Receptor for Advanced Glycation End Products | 1 | 2019 | 100 | 0.18 | Why? |
| Infusion Pumps | 1 | 2018 | 44 | 0.18 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.18 | Why? |
| Ketosis | 1 | 2018 | 44 | 0.17 | Why? |
| Retrospective Studies | 18 | 2021 | 105322 | 0.17 | Why? |
| Adult | 28 | 2021 | 244371 | 0.17 | Why? |
| Chemokine CCL2 | 1 | 2019 | 389 | 0.17 | Why? |
| Male | 30 | 2021 | 367725 | 0.17 | Why? |
| Acidosis | 1 | 2018 | 125 | 0.16 | Why? |
| Femoral Artery | 1 | 2018 | 213 | 0.16 | Why? |
| Brain Edema | 1 | 2018 | 224 | 0.16 | Why? |
| Fibrinolysis | 1 | 2021 | 521 | 0.16 | Why? |
| Corpus Callosum | 1 | 2018 | 182 | 0.15 | Why? |
| Humans | 45 | 2021 | 930598 | 0.15 | Why? |
| Survivors | 2 | 2019 | 2619 | 0.15 | Why? |
| Female | 29 | 2021 | 380317 | 0.15 | Why? |
| Catheterization, Peripheral | 1 | 2018 | 249 | 0.14 | Why? |
| Enterobacteriaceae | 1 | 2019 | 395 | 0.14 | Why? |
| Equipment and Supplies, Hospital | 1 | 2017 | 272 | 0.14 | Why? |
| Ambulances | 1 | 2017 | 287 | 0.14 | Why? |
| Microcirculation | 1 | 2018 | 447 | 0.14 | Why? |
| Blood Gas Analysis | 1 | 2018 | 893 | 0.14 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.13 | Why? |
| Inventions | 1 | 2018 | 372 | 0.13 | Why? |
| Renal Insufficiency | 1 | 2021 | 810 | 0.13 | Why? |
| Aged | 16 | 2021 | 215776 | 0.13 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.13 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.13 | Why? |
| Enterobacteriaceae Infections | 1 | 2019 | 529 | 0.12 | Why? |
| Pulmonary Edema | 1 | 2017 | 430 | 0.12 | Why? |
| beta-Lactamases | 1 | 2019 | 759 | 0.12 | Why? |
| Survival Analysis | 4 | 2021 | 7592 | 0.12 | Why? |
| Hemorrhage | 2 | 2021 | 3013 | 0.11 | Why? |
| Dyspnea | 3 | 2020 | 3847 | 0.10 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 2309 | 0.10 | Why? |
| Patient Transfer | 1 | 2017 | 898 | 0.10 | Why? |
| Systemic Inflammatory Response Syndrome | 2 | 2020 | 6653 | 0.10 | Why? |
| Lung Transplantation | 1 | 2021 | 1554 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.09 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.09 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.09 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.08 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.08 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.08 | Why? |
| Heparin | 1 | 2018 | 2600 | 0.07 | Why? |
| Tertiary Care Centers | 3 | 2017 | 8248 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| von Willebrand Factor | 2 | 2021 | 668 | 0.07 | Why? |
| Aged, 80 and over | 4 | 2019 | 88759 | 0.07 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 2984 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| Influenza, Human | 2 | 2018 | 10779 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Interleukin-6 | 1 | 2019 | 7522 | 0.06 | Why? |
| Attitude of Health Personnel | 1 | 2019 | 4741 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2019 | 4927 | 0.05 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.05 | Why? |
| Asthenia | 1 | 2020 | 107 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Anti-Bacterial Agents | 2 | 2019 | 10083 | 0.05 | Why? |
| Tachycardia | 1 | 2020 | 239 | 0.05 | Why? |
| Practice Guidelines as Topic | 2 | 2021 | 15421 | 0.05 | Why? |
| Coronary Care Units | 1 | 2020 | 224 | 0.05 | Why? |
| Pipecolic Acids | 1 | 2018 | 84 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.04 | Why? |
| Hypotension | 1 | 2020 | 392 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Escherichia coli Proteins | 1 | 2017 | 168 | 0.04 | Why? |
| Conjunctivitis | 1 | 2020 | 318 | 0.04 | Why? |
| Chest Pain | 1 | 2020 | 578 | 0.04 | Why? |
| Arginine | 1 | 2018 | 377 | 0.04 | Why? |
| Acute Disease | 2 | 2019 | 6029 | 0.04 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.04 | Why? |
| Abdominal Pain | 1 | 2020 | 858 | 0.03 | Why? |
| Fibrinogen | 1 | 2020 | 1048 | 0.03 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.03 | Why? |
| Diagnosis, Differential | 2 | 2018 | 7220 | 0.03 | Why? |
| Glucose | 1 | 2018 | 573 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.03 | Why? |
| Treatment Failure | 1 | 2019 | 2106 | 0.03 | Why? |
| Cannula | 1 | 2018 | 750 | 0.03 | Why? |
| Platelet Count | 1 | 2018 | 1381 | 0.03 | Why? |
| Standard of Care | 1 | 2019 | 1297 | 0.03 | Why? |
| Anemia, Sickle Cell | 1 | 2018 | 546 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.03 | Why? |
| Exanthema | 1 | 2020 | 1097 | 0.03 | Why? |
| Coronary Angiography | 1 | 2020 | 2275 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.03 | Why? |
| Stroke Volume | 1 | 2020 | 2153 | 0.03 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.03 | Why? |
| Headache | 1 | 2020 | 2257 | 0.02 | Why? |
| Peptide Fragments | 1 | 2020 | 2075 | 0.02 | Why? |
| Health Care Surveys | 1 | 2019 | 2942 | 0.02 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.02 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.02 | Why? |
| Acute Lung Injury | 1 | 2017 | 904 | 0.02 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.02 | Why? |
| Equipment Contamination | 1 | 2017 | 1308 | 0.02 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.02 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.02 | Why? |
| Heart Transplantation | 1 | 2018 | 1293 | 0.02 | Why? |
| Internationality | 1 | 2019 | 3297 | 0.02 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.02 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.02 | Why? |
| Risk Factors | 3 | 2019 | 71621 | 0.02 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.01 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.01 | Why? |
| Critical Care | 1 | 2018 | 14081 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.01 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.00 | Why? |
Schmidt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(150)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_